Page last updated: 2024-10-18

dalteparin and Papulosquamous Disorders

dalteparin has been researched along with Papulosquamous Disorders in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
" We describe a female patient, whose localized reaction from dalteparin was followed by a generalized rash presenting as acute generalized exanthematous pustulosis."7.74Acute generalized exanthematous pustulosis from dalteparin. ( Aberer, W; Grims, R; Komericki, P; Kränke, B, 2007)
" We describe a female patient, whose localized reaction from dalteparin was followed by a generalized rash presenting as acute generalized exanthematous pustulosis."3.74Acute generalized exanthematous pustulosis from dalteparin. ( Aberer, W; Grims, R; Komericki, P; Kränke, B, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komericki, P1
Grims, R1
Kränke, B1
Aberer, W1

Other Studies

1 other study available for dalteparin and Papulosquamous Disorders

ArticleYear
Acute generalized exanthematous pustulosis from dalteparin.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:4

    Topics: Acute Disease; Anticoagulants; Dalteparin; Drug Eruptions; Exanthema; Female; Humans; Injections; Mi

2007